Delta9-tetrahydrocannabinol decreases somatic and motivational manifestations of nicotine withdrawal in mice

The possible interactions between Delta9-tetrahydrocannabinol (THC) and nicotine remain unclear in spite of the current association of cannabis and tobacco in humans. The aim of the present study was to explore the interactions between these two drugs of abuse by evaluating the consequences of THC administration on the somatic manifestations and the aversive motivational state associated to nicotine withdrawal in mice. Acute THC administration significantly decreased the incidence of several nicotine withdrawal signs precipitated by mecamylamine or naloxone, such as wet-dog-shakes, paw tremor and scratches. In both experimental conditions, the global withdrawal score was also significantly attenuated by acute THC administration. THC also reversed conditioned place aversion associated to naloxone precipitated nicotine withdrawal. We have then evaluated whether this effect of THC was due to possible adaptive changes induced by chronic nicotine on CB1 cannabinoid receptors. The stimulation of GTPS-binding proteins by the cannabinoid agonist WIN 55,212-2 and the density of CB1 cannabinoid receptor binding labelled with [3H] CP-55,940 were not modified by chronic nicotine treatment in the different brain structures investigated. Finally, we evaluated the consequences of THC administration on c-Fos expression in several brain structures after chronic nicotine administration and withdrawal. c-Fos was decreased in the caudate putamen and the dentate gyrus after mecamylamine precipitated nicotine withdrawal. However, acute THC administration did not modify c-Fos expression under these experimental conditions. Taken together, these results indicate that THC administration attenuated somatic signs of nicotine withdrawal and this effect was not associated to compensatory changes on CB1 cannabinoid receptors during chronic nicotine administration. In addition, THC also ameliorated the aversive motivational consequences of nicotine withdrawal.This work has been supported by grants from Human Frontier Science Program Organization (RG0077/2000-B), Plan Nacional sobre Drogas, Generalitat de Catalunya (Research Distinction), 2002 SGR00193 and the European Comission “Quality of Life and Management of Living Resources QLRT-2001-01691. Graciela Balerio is a postdoctoral fellow supported by “Fundación Carolina”. Fernando Berrendero is a researcher supported by “Ramón y Cajal” research program of the Ministery of Science and Technology

Óleo de copaíba (Copaifera sp.): histórico, extração, aplicações industriais e propriedades medicinais Copaiba oil (Copaifera sp.): history, extraction, industrial applications and medicinal properties

Este trabalho teve como objetivo realizar uma revisão de literatura sobre o gênero Copaifera sp. Foi realizado levantamento bibliográfico do período de 1792 a 2008 utilizando bibliotecas da Universidade de São Paulo, Universidade Federal de Viçosa, Universidade Federal de Alfenas e Universidade José do Rosário Vellano, pesquisas às bases de dados SCOPUS e PubMed, além de ferramentas de busca na web. Utilizou-se para a busca palavras chave como "Copaiba", "Copaifera", "Copaíba oil" "Óleo de Copaíba". Como resultado desta pesquisa obteve-se a seleção de 63 referências incluindo livros, artigos, cadernos técnicos, resumos de congressos, teses, dissertações e patentes. Estes dados apontaram o óleo de copaíba como um exsudato produzido pelas copaibeiras como defesa contra seus predadores, que vem sendo utilizado pela medicina tradicional popular e silvícola há mais de 500 anos. Ele é extraído destas árvores através de perfurações realizadas em seus troncos. Além das inúmeras aplicações do óleo em cosméticos e outras indústrias, ainda há uma série de indicações para seu uso na medicina. Existem hoje descritas algumas dezenas de propriedades medicinais diferentes, que vem sendo em alguns casos comprovadas cientificamente, como atividade antimicrobiana, antiinflamatória, anti-neoplásica entre outras. Estudos recentes têm demonstrado também grande potencial de uso do óleo de copaíba na odontologia, na composição de cimentos endodônticos e na prevenção e combate da doença periodontal. As informações contidas neste trabalho demonstram uma grande variabilidade de aplicações do óleo de copaíba. Entretanto uma quantidade limitada de pesquisas sobre suas propriedades medicinais tem sido realizada, apresentando assim a necessidade de novas pesquisas sobre estas.<br>The aim of this study was to conduct a literature review concerning the genus Copaifera sp. The survey involved the period from 1792 to 2008 and was done in the libraries of University of São Paulo, Federal University of Viçosa, Federal University of Alfenas and University Jose do Rosario Vellano, using SCOPUS and PubMed databases, and web search engines. The words "Copaiba", "Copaifera," "Óleo de copaiba" and "Copaiba oil" were used. This research resulted in the selection of 63 references including books, articles, technical specifications, conference abstracts, theses, dissertations and patents. These data indicate copaiba oil is an exudate from copaiba trees, produced as a defense against their predators and that has been used in traditional, popular and forestry medicine for over 500 years. It is extracted from trees through holes made in their trunks. Besides the oil applications in cosmetic and other industries, there are still a number of indications for its use in medicine. So far, dozens of different medicinal properties have been described and, in some cases, scientifically proven, including antimicrobial, anti-inflammatory, and anti-cancer activity. Recent studies have also shown great potential for the use of copaiba oil in dentistry like in endodontic cement composition, as well as in the prevention and therapy of periodontal diseases. This work showed a great variety of applications to copaiba oil. However, few studies on its medicinal properties have been performed, showing thus the need for further research